In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing for a healthcare partner in Puerto Rico. By the end of November, CTS implements universal individual Zika testing on all blood donations in the US, due to an FDA requirement.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...